Focus AP v2
Natural health product licensed in Canada
- Other names
- Focus AP
- Licence holder
- Melaleuca of Canada Inc.
- NPN or DIN-HM
- 80143832
- Status
- Active licence
- Licence date
- 3 September 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 7,9-Dihydro-1,3,7,9-tétraméthyl-1H-purine-2,6,8(3H)-trione Source : Théacrine | 50 mg | Not calculated |
| 2-Méthoxy-1,7,9-triméthylpurine-6,8-dione Source : Méthyllibérine | 75 mg | Not calculated |
| 1,3,7-triméthylxanthine Source : Coffea canephora - Graine | 100 mg | Not calculated |
| Coffea canephora Source : Coffea canephora - Graine Potency : 60 % Caffeine | 83 mg | Not calculated |
| Coffea arabica Source : Coffea arabica - Fruit Potency : 40 % Chlorogenic acids | 100 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Silicate de calcium, Copolymère d'acide méthacrylique et d'acrylate d'éthyle, Chlorure de potassium, Dioxyde de silicium, Cellulose microcristalline, Gomme-laque, Hypromellose, Carraghénine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to support/promote mental sharpness/alertness. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Helps (temporarily) to enhance (physical) energy. Helps (temporarily) to reduce tiredness and fatigue. Source of/Provides antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80143832
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.